MICHELLE SMITH: Open Payments
NPI 1730883661 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,526 in 151 payments from 17 companies in 2025. Trend: 2023 $2,004 · 2024 $2,640 · 2025 $2,526
Food & beverage: $2,526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $578 |
| Novartis Pharmaceuticals Corporation | 22 | $385 |
| Amgen Inc. | 35 | $370 |
| UCB, Inc. | 12 | $227 |
| Janssen Biotech, Inc. | 10 | $159 |
| Mallinckrodt Hospital Products Inc. | 5 | $141 |
| Radius Health, Inc. | 5 | $139 |
| ANI Pharmaceuticals, Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Lilly USA, LLC | 4 | $78 |
Products named: SKYRIZI, COSENTYX, Bimzelx, RINVOQ, OTEZLA, TREMFYA, ACTHAR, EVENITY.
Industry payments across MS — which companies pay providers there.
